NTRA

Natera, Inc.

86.40 USD
+9.85 (+12.87%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Natera, Inc. stock is up 30.91% since 30 days ago. The next earnings date is May 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 8 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 6 PUTs, 4 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
11 Jan 19:40 19 Jan, 2024 65.00 PUT 84 55
11 Jan 20:24 19 Jan, 2024 65.00 PUT 87 55
12 Jan 15:27 19 Jan, 2024 60.00 PUT 305 1774
12 Jan 15:28 16 Feb, 2024 65.00 PUT 118 9
12 Jan 19:27 16 Feb, 2024 65.00 CALL 153 40
19 Jan 14:50 19 Apr, 2024 55.00 PUT 599 727
01 Feb 14:45 16 Feb, 2024 70.00 CALL 500 269
01 Feb 16:15 16 Feb, 2024 70.00 CALL 206 269
27 Feb 18:57 18 Oct, 2024 50.00 CALL 20 0
28 Feb 20:23 15 Mar, 2024 80.00 PUT 86 0

About Natera, Inc.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage.

  • Canaccord Genuity
    Thu Feb 29, 08:02
    buy
    confirm
  • Raymond James
    Tue Feb 20, 11:11
    buy
    confirm